<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="21650">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01847612</url>
  </required_header>
  <id_info>
    <org_study_id>PI 2013-843-0003</org_study_id>
    <secondary_id>2013-000408-40</secondary_id>
    <nct_id>NCT01847612</nct_id>
  </id_info>
  <brief_title>Use of Indocyanine Green Cholangiography and Methylene Blue to Detect Postoperative Biliary Fistula After Hepatectomy</brief_title>
  <acronym>CAMFIB</acronym>
  <official_title>Evaluation of Indocyanine Green Fluorescent Cholangiography Versus Methylene Blue to Detect Postoperative Biliary Fistula After Hepatectomy: Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <authority>France: Committee for the Protection of Personnes</authority>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present study is to evaluate whether the use of indocyanine green fluorescent
      cholangiography is responsible in a decrease of biliary fistula's rate in patients with
      liver diseases requiring liver resection.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>biliary fistula rate</measure>
    <time_frame>postoperative week 4</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>the biliary fistula is defined as a bilirubin in the drain three times higher than the serum bilirubin.
the primary endpoint will be evaluated by a medical committee composed by investigators not involved in the patients enrollment.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">132</enrollment>
  <condition>Liver Disease</condition>
  <arm_group>
    <arm_group_label>indocyanine green fluorescent cholangiography</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>use of indocyanine green fluorescent cholangiography in the patients of this arm, an indocyanine green fluorescent cholangiography is performed</description>
  </arm_group>
  <arm_group>
    <arm_group_label>methylene blue</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>injection of methylene blue during the surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>indocyanine green fluorescent cholangiography</intervention_name>
    <arm_group_label>indocyanine green fluorescent cholangiography</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>methylene blue</intervention_name>
    <arm_group_label>methylene blue</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  benin or malignant liver disease with resection of 2 or more segments

          -  liver resection by laparotomy

          -  written consent

        Exclusion Criteria:

          -  previous hepatectomy

          -  emergency surgery

          -  allergy to indocyanine green

          -  allergy to methylene blue

          -  pregnancy or breastfeeding
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>jean marc regimbeau, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU amiens</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>jean marc regimbeau, MD, phD</last_name>
    <phone>+33 3 22 66 83 00</phone>
    <email>regimbeau.jean-marc@chu-amiens.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Amiens University Hospital</name>
      <address>
        <city>Amiens</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>jean marc regimbeau, MD, PhD</last_name>
      <phone>+33 3 22 66 83 00</phone>
      <email>regimbeau.jean-marc@chu-amiens.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Nguyen-Khac E, Lobry C, Chatelain D, Fuks D, Joly JP, Brevet M, Tramier B, Mouly C, Hautefeuille V, Chauffert B, Regimbeau JM. A Reappraisal of Chemotherapy-Induced Liver Injury in Colorectal Liver Metastases before the Era of Antiangiogenics. Int J Hepatol. 2013;2013:314868. doi: 10.1155/2013/314868. Epub 2013 Mar 7.</citation>
    <PMID>23533786</PMID>
  </reference>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 26, 2013</lastchanged_date>
  <firstreceived_date>April 30, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>per operative cholangiography</keyword>
  <keyword>liver resection</keyword>
  <keyword>biliary fistula</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Biliary Fistula</mesh_term>
    <mesh_term>Fistula</mesh_term>
    <mesh_term>Liver Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Methylene Blue</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
